Australia
Industry
Boosting Australia's reputation for high quality biomedical R&D, the Therapeutic Goods Administration (TGA) has approved local firm CSL's avian influenza vaccine, Panvax. Launch...
2008-06-20Industry
Australian pharmaceutical and healthcare company Sigma Pharmaceuticals is concentrating on high-margin products to maintain financial health in an increasingly challenging operating...
2008-03-26Industry
Reinforcing its position as one of Australia's leading drugmakers, Sigma Pharmaceuticals has acquired compatriot firm Orphan Holdings. The AUD130mn (US$113mn) deal gives Sigma an...
2007-12-24Companies
In a blow to efficiency and a victory for nationalism, plans for a combined Australia/New Zealand agency for the approval of medicines have been deferred until there is more support...
2007-07-17Companies
UK-based drugmaker GlaxoSmithKline (GSK)'s cervical cancer vaccine Cervarix has been approved in Australia, its first major market. This news is a bright note for GSK after the...
2007-05-23Companies
Creating a world class antibody powerhouse, the Australian biotechnology firms Peptech and EvoGenix are to merge in an AUD156mn (US$130mn) deal. BMI is expecting great things from...
2007-05-15Companies
Australian biotechnology firm Biota has increased its damages claim against UK-based multinational GlaxoSmithKline, alleging that its senior development partner for its influenza...
2007-04-02Companies
Pharmaceuticals and biotechnology firms have outperformed other industries in Australia in terms of share price in the past 21 years, according to analysis from research firm
2007-01-11




